Is SGI Stock Worth Buying Amid Growth Gains and Execution Risks?

Somnigroup’s broad bedding platform spans manufacturing, distribution, retail and e-commerce operations across more than 100 countries. The company operates through Tempur Sealy, Mattress Firm and Dreams, with brands including Tempur-Pedic, Sealy, Stearns & Foster and Sleepy’s.

The company continues to benefit from its scale and diversified channels, but softer consumer demand remains a major challenge. In the second quarter of 2026, net sales declined 3% year over year to $1.82 billion, missing the Zacks Consensus Estimate of $1.9 billion. Management also lowered its view of the global bedding market, expecting the industry to decline by a mid-single-digit percentage in 2026.

Somnigroup expects 2026 sales growth to rely on pricing actions, acquisition-related synergies and market share gains rather than a broad-based demand recovery. The company projects Tempur Sealy North America like-for-like sales growth in the low-single digits, low-single-digit international growth and a slight decline in Mattress Firm like-for-like sales.

Investors evaluating Somnigroup can also compare the company with other players in the home furnishings and bedding industry, including Floor & Decor Holdings, Inc. FND and Leggett & Platt, Incorporated LEG.

Somnigroup Synergies Support Future Earnings

The Mattress Firm acquisition remains a key part of Somnigroup’s long-term earnings strategy. The company continues to increase Tempur Sealy brand penetration at Mattress Firm, with management expecting Tempur Sealy brands and private labels to represent a mid-60s percentage of Mattress Firm sales in 2026. This is expected to contribute an incremental $65 million of adjusted EBITDA benefit compared with 2025.

Somnigroup realized about $30 million of net sales and cost synergy benefits in the second quarter, including roughly $15 million of cost synergies. Tempur Sealy North America also benefited from acquisition synergies, operational efficiencies and favorable product mix, which helped adjusted gross margin expand 680 basis points year over year to 61.8%.

International operations provide additional diversification. Tempur Sealy International sales increased 2% year over year in the second quarter, while the company continued expanding its retail footprint through acquisitions and owned-store growth initiatives.

SGI Faces Margin And Execution Risks

Despite progress on synergies, profitability remains pressured by several factors. Mattress Firm sales declined 2.8% in the second quarter to $922.2 million, primarily due to store closures, while adjusted gross margin fell 240 basis points to 33.3%. Higher consumer financing costs, store investments and deleveraging weighed on margins.

Commodity inflation has also created near-term pressure. Management estimated roughly $90 million of annualized commodity inflation and noted that higher input and freight costs affected profitability before pricing actions were implemented. The company expects pricing actions to offset these pressures in the second half of 2026, although management acknowledged that pricing can be margin dilutive even when it recovers dollar costs.

Demand recovery remains another uncertainty. Management cited weaker-than-expected industry trends, a challenging U.K. market and temporary ERP-related disruption at Dreams as factors that influenced the reduction in 2026 guidance.

Somnigroup Valuation Requires Patience

SGI shares have declined 27.4% year to date, reflecting investor concerns about industry weakness and earnings visibility. The stock trades at 18.7X forward 12-month earnings, below the Zacks sub-industry average of 20.6X and the S&P 500 average of 20.8X.

The valuation reflects a balance between Somnigroup’s long-term growth opportunities and near-term operating challenges. Stronger cash generation and lower leverage provide financial flexibility, but slower demand recovery and reduced earnings expectations remain constraints.

The company generated $482.8 million of operating cash flow in the first six months of 2026, including record second-quarter operating cash flow of $236 million. Net debt declined by more than $500 million over the trailing 12 months, while leverage improved to 2.99 times at June 30, 2026. 

Image Source: Zacks Investment Research

SGI Signals Point To A Cautious Outlook

The stock currently carries a Zacks Rank #5 (Strong Sell), with a VGM Score of C. SGI also has a Value Score of D, Growth Score of B and Momentum Score of C.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Style Scores are designed to complement the Zacks Rank by evaluating characteristics such as value, growth and momentum. While SGI’s Growth Score of B reflects favorable growth-related factors, the overall Zacks Rank indicates that downward earnings estimate trends remain a key concern.

With improving synergies, stronger cash flow and long-term platform benefits balanced against weak bedding demand, margin pressure and execution risks, SGI appears better suited for investors willing to wait for a clearer recovery in industry conditions. The current Zacks indicators suggest caution until earnings visibility improves. 

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research